A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Inclusion Criteria: * Healthy male or non pregnant female aged ≥ 18 years * Subjects must have provided IRB approved written informed consent * Subjects must have clinical diagnosis of interdigital tinea pedis with lesions localized to the interdigital spaces or predominantly interdigital, but may extend to other areas of the foot (the non-interdigital lesions should not be hyperkeratotic, i.e., characteristic of tinea pedis moccasin). Exclusion Criteria: * Female Subjects who are pregnant, nursing or planning to become pregnant during study participation. * Subjects with a history of hypersensitivity or allergy to any of the study medication ingredients and its excipients. * Confluent, diffuse moccasin-type tinea pedis of the entire plantar surface.